Table of Contents Author Guidelines Submit a Manuscript
Case Report
Case Reports in Dentistry
Volume 2017, Article ID 4383926, 2 pages
Letter to the Editor

Comment on “World’s First Clinical Case of Gene-Activated Bone Substitute Application”

1Kazan (Volga Region) Federal University, Kazan, Russia
2Republic Clinical Hospital, Kazan, Russia

Correspondence should be addressed to Albert A. Rizvanov; ur.ufpk@vonavzir.trebla

Received 29 November 2016; Accepted 10 January 2017; Published 12 July 2017

Academic Editor: Luis M. J. Gutierrez

Copyright © 2017 Albert A. Rizvanov and Ruslan F. Masgutov. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Y. Bozo, R. V. Deev, A. Y. Drobyshev, A. A. Isaev, and I. I. Eremin, “World’s first clinical case of gene-activated bone substitute application,” Case Reports in Dentistry, vol. 2016, Article ID 8648949, 6 pages, 2016. View at Publisher · View at Google Scholar
  2. R. Masgutov, M. Chekunov, M. Zhuravleva et al., “Use of gene-activated demineralized bone allograft in the therapy of ulnar pseudarthrosis. case report,” BioNanoScience, vol. 7, no. 1, pp. 194–198, 2017. View at Publisher · View at Google Scholar
  3. R. V. Deev, I. Y. Bozo, N. D. Mzhavanadze et al., “pCMV-vegf165 intramuscular gene transfer is an effective method of treatment for patients with chronic lower limb ischemia,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 20, no. 5, pp. 473–482, 2015. View at Publisher · View at Google Scholar
  4. R. V. Deev, A. Y. Drobyshev, I. Y. Bozo, and A. A. Isaev, “Ordinary and activated bone grafts: applied classification and the main features,” BioMed Research International, vol. 2015, Article ID 365050, 19 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus